Last reviewed · How we verify
NCT06835634: PANDA
Progressive Advancements in Neurosurgery, Data and Analysis Database
trial testing Self reported questionnaires in Spine Disease in 7,500 participants. Participants enrolled and being followed up; not accepting new ones.
10 February 2035
Quick facts
| Lead sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 7,500 |
| Start date | 15 January 2025 |
| Primary completion | 10 February 2035 |
| Estimated completion | 31 December 2035 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Self reported questionnaires
Conditions studied
- Spine Disease — all drugs for Spine Disease →
- Central Nervous System Diseases — all drugs for Central Nervous System Diseases →
- Peripheral Nervous System Diseases — all drugs for Peripheral Nervous System Diseases →
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Who can join
18 and older, any sex, with Spine Disease or Central Nervous System Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Neurosurgical diseases encompass a highly heterogeneous group of conditions, including oncological, malformative, traumatic, spinal, vascular, infectious diseases, and cerebrospinal fluid dynamics disorders. Several systematic reviews on the level of evidence in neurosurgical diseases have documented the low percentage of high-quality scientific evidence in this field of medicine. Clinical practice is strongly influenced by individual physician preferences, leading to significant heterogeneity among different centers both in Italy and internationally. This overall picture highlights the need for tools that can accurately characterize the numerous diagnostic variables influencing therapeutic outcomes in patients with neurosurgical diseases. Primary Objective To establish a prospective data collection of adult patients with neurosurgical diseases, providing real-life data on the current management of patients at the Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome and the participating centers. Secondary Objectives To create a database of adult patients with neurosurgical diseases who may be potential candidates for enrollment in clinical trials. To conduct observational research on neurosurgical diseases, particularly in cases where no curative treatment options are currently available. To identify potential predictors of poor outcomes or treatment response. To assess the clinical history and treatment response of patients, including for internal audit purposes (e.g., supporting Morbidity \& Mortality conferences). To provide support for the development and monitoring of quality indicators related to patient care.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A visual mining analysis of middle meningeal embolization and other factors associated with recurrence requiring re-operation in subdural hematomas: a single-center series.
Battistelli M, Vezzoli M, Valente I, Benenati M, et al · · 2025 · PMID 41420704 · DOI 10.1007/s00701-025-06737-8
Verify or expand the search:
- PubMed search for NCT06835634
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Spine Disease
Currently open trials in the same condition.
- NCT07180940 — Comparison of Perineural Dexamethasone Versus Dexmedetomidine as Adjuvants to Erector Spinae Plane Block in Lumbar Spine · Phase 4 · recruiting
- NCT07017985 — Prevalence of Diabetes in Patients Who Are Candidates for Spine Surgery · recruiting
- NCT06233617 — Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Spine Surgery · Phase 4 · recruiting
- NCT06400680 — Gait Spine Functional Evaluation Protocol · NA · active not recruiting
- NCT05473689 — Outcomes Post Treatment: Impact on Motor Impairment of Sleep Efficiency in SCI (OPTIMISE SCI Trial) · NA · recruiting
Other Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials
Trials by the same sponsor.
- NCT07514572 — Impact of Estimated Weight and Height on Nutritional Assessment in Elderly · NA · not yet recruiting
- NCT07504679 — Adipose Visceral and Epicardial Risk Evaluation · NA · not yet recruiting
- NCT07520643 — MISTIC Study: Atherosclerosis, Neurocognition & Cardiovascular Signaling · not yet recruiting
- NCT07479238 — Breath Test-Based Assessment of SIBO in Chronic Pancreatitis and Partial Pancreatectomy · not yet recruiting
- NCT07494227 — Development of the SC-IBD Self-Care Measurement Scale · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06835634 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Last refreshed: 19 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06835634.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing